Bill · H.Res. 1060· House(119-HRES-1060)
Expressing support for the designation of April 5, 2026, as "Barth Syndrome Awareness Day".
- Introduced
- 2/11/2026
- Last activity
- 2/11/2026 — Referred to the House Committee on Energy and Commerce.
- Sponsored by
- Paul Tonko
- Cosponsors
- - 7 - 4
- Introduced
- In Committee
A House resolution is the House speaking for itself: stating a position, honouring someone, or setting its own rules. Adopting it is the whole process. Once the House agrees to it, it is officially the House's word; it is not a law, so the Senate and the President have no part in it.
What this bill would do
This resolution expresses support for designating April 5, 2026, as "Barth Syndrome Awareness Day." The bill highlights that Barth syndrome is a rare, life-threatening genetic disorder caused by a mutation in the tafazzin gene. It notes that the disorder affects multiple body systems and can lead to death in early childhood. The resolution emphasizes the need for increased research, better diagnosis, and new treatments. Finally, it seeks to recognize the importance of improving awareness and advancing medical developments for this condition.
Yes· 3 of 6
Would children be better off under this?+5
The resolution focuses on a life-threatening disorder that primarily causes death in early childhood.
Would men be better off under this?+4
The resolution notes that Barth syndrome primarily affects males.
Would people with disabilities be better off under this?+4
The bill advocates for better diagnostic and treatment pathways for a rare genetic disorder.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Increased Awareness and Information: The designation of "Barth Syndrome Awareness Day" is expected to provide hope and information for patients, caregivers, and families across the country. (Resolution Section 1 and Whereas clauses regarding the Barth Syndrome Foundation).
-
Improved Medical Outcomes: The resolution recognizes the importance of encouraging accurate and early diagnosis, which is vital as patients often face challenges obtaining a diagnosis. (Resolution Section 2, Part B).
-
Advancement of Treatments: There is a focus on advancing research and developing new treatments, diagnostics, and cures for those suffering from this life-threatening disorder. (Resolution Section 2, Parts C and D).
-
Improved Regulatory Pathways: The resolution recognizes the importance of identifying regulatory pathways for drug development for ultrarare diseases like Barth syndrome. (Resolution Section 2, Part E).
Potential Negative Impacts for People
- No negative impacts or burdens are explicitly mentioned in the text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Children+5Good For Men+4Good For People With Disabilities+4Good For Young Adults+2
- Healthcare
- Improves Healthcare Access+3Increases Research Funding+3
- 3/19/2026
- 1 Cosponsor added.
- 2/11/2026
- Submitted in House
- Referred to the House Committee on Energy and Commerce.
- 10 Cosponsors added.
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Jake AuchinclossDemocrat · Massachusetts
Gus BilirakisRepublican · Florida
Sheri BiggsRepublican · South Carolina
Sharice DavidsDemocrat · Kansas
Valerie FousheeDemocrat · North Carolina
George LatimerDemocrat · New York
Doris MatsuiDemocrat · California
Morgan McGarveyDemocrat · Kentucky
Ralph NormanRepublican · South Carolina
Lori TrahanDemocrat · Massachusetts
Joe WilsonRepublican · South Carolina